Literature DB >> 12110420

Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures.

C Fiorano-Charlier1, A Ostertag, J P Aquino, M-C de Vernejoul, C Baudoin.   

Abstract

Postmenopausal fractures are associated with low bone mass; however, the role of low peak bone mass in young adults in determining subsequent osteoporosis suggests that premenopausal fractures may also be relevant. We therefore sought to determine whether a self-reported previous history of premenopausal wrist and nonwrist fractures could also be associated with bone density and therefore be used to predict osteoporosis. We recruited 453 volunteer women with a median age of 64 years (range 50-83 years), with no metabolic bone disease, previous femoral neck fracture, or prevalent vertebral fracture. Bone density at the femoral neck (FN) and lumbar spine (LS) was measured using a Lunar DPX-L. As expected, the 319 women who did not report any fracture had a higher T score at LS (-0.93 +/- 1.44) than the 134 women who reported a previous fracture at any site and at any age (T score -1.60 +/- 1.21, p < 0.001). The findings for the FN were similar. Compared with fracture-free women, the women who reported a first wrist fracture before menopause now had a lower LS T score (-1.77 +/- 1.20, n = 15, p < 0.05), whereas those who reported a nonwrist fracture showed no significant decrease in their LS T score (-1.26 +/- 1.00, n = 36). When both wrist and nonwrist fractures had occurred after menopause, the T score was significantly lower. Twenty percent of the fracture-free women were osteoporosis patients. After adjusting for body weight, age, hormonal replacement therapy (HRT), and hip fracture in the family, the relative risk (RR) of osteoporosis for premenopausal wrist fractures was 2.7 (95% confidence interval 1.4-4.3) vs. 1.2 (0.7-2.4) for women with premenopausal nonwrist fractures. We conclude that self-reported premenopausal wrist fractures, but no other fractures occurring before menopause, are likely to be associated with osteoporosis at 65 years of age, and therefore constitute strong grounds for screening.

Entities:  

Mesh:

Year:  2002        PMID: 12110420     DOI: 10.1016/s8756-3282(02)00778-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

Review 1.  Treatment of low bone mass in premenopausal women: when may it be appropriate?

Authors:  Edward S Leib
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

Review 2.  Premenopausal bone health assessment.

Authors:  E Michael Lewiecki
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

3.  Prior fracture as a risk factor for future fracture in an Australian cohort.

Authors:  K L Holloway; S L Brennan; M A Kotowicz; G Bucki-Smith; E N Timney; A G Dobbins; L J Williams; J A Pasco
Journal:  Osteoporos Int       Date:  2014-09-18       Impact factor: 4.507

4.  Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics.

Authors:  Jean-Michel Pouillès; Florence A Trémollieres; Claude Ribot
Journal:  Osteoporos Int       Date:  2005-07-15       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.